A 4-year-old child presents to the clinic with eczema (atopi…

A 4-year-old child presents to the clinic with eczema (atopic dermatitis) characterized by dry, itchy patches on the face, elbows, and knees. The child has been using over-the-counter moisturizers and hydrocortisone cream without significant improvement. The healthcare provider decides to start the child on a prescription treatment for better symptom control. Which of the following is the most appropriate first-line prescription treatment for this child’s eczema?

A 45-year-old patient with actinic keratosis presents to the…

A 45-year-old patient with actinic keratosis presents to the clinic and is prescribed imiquimod (Aldara) for treatment. The FNP is educating the patient about the correct dosing schedule. Which of the following is the most appropriate dosing regimen for this patient?

A 28-year-old patient with atopic dermatitis (eczema) is bei…

A 28-year-old patient with atopic dermatitis (eczema) is being discharged after an initial consultation with their primary care provider. The healthcare provider discusses the importance of self-care and skin management to reduce flare-ups and manage symptoms. The patient is instructed on various aspects of daily skincare and lifestyle changes. Which of the following patient education points is most important for this patient to understand in managing their dermatitis effectively?

A 5-year-old patient is diagnosed with impetigo, a highly co…

A 5-year-old patient is diagnosed with impetigo, a highly contagious bacterial skin infection caused by Streptococcus pyogenes and Staphylococcus aureus. The healthcare provider prescribes treatment based on the severity and type of impetigo. Which of the following pharmacological treatments is most appropriate for a child with non-bullous impetigo? 

A 38-year-old female patient presents with plaque psoriasis…

A 38-year-old female patient presents with plaque psoriasis affecting her scalp, elbows, and knees. She has tried over-the-counter hydrocortisone cream with limited success, and her psoriasis has been persistent despite using stronger topical corticosteroids for the past few months. The healthcare provider is considering additional or alternative topical therapies to improve symptom control and reduce inflammation. Which of the following topical therapies would most likely be beneficial for this patient as an adjunctive treatment for her psoriasis?